Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Capital Expenditures (2016 - 2025)

KalVista Pharmaceuticals' Capital Expenditures history spans 10 years, with the latest figure at $342000.0 for Q2 2025.

  • On a quarterly basis, Capital Expenditures rose 235.71% to $342000.0 in Q2 2025 year-over-year; TTM through Apr 2025 was $219000.0, a 421.43% increase, with the full-year FY2025 number at $495000.0, up 1078.57% from a year prior.
  • Capital Expenditures hit $342000.0 in Q2 2025 for KalVista Pharmaceuticals, up from $65000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for KALV hit a ceiling of $342000.0 in Q2 2025 and a floor of -$252000.0 in Q2 2024.
  • Historically, Capital Expenditures has averaged $73285.7 across 3 years, with a median of $64000.0 in 2024.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 3150.0% in 2024 and later skyrocketed 235.71% in 2025.
  • Tracing KALV's Capital Expenditures over 3 years: stood at $2000.0 in 2023, then skyrocketed by 3150.0% to $65000.0 in 2024, then skyrocketed by 426.15% to $342000.0 in 2025.
  • Business Quant data shows Capital Expenditures for KALV at $342000.0 in Q2 2025, $65000.0 in Q4 2024, and $64000.0 in Q3 2024.